These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25748204)

  • 1. Preclinical studies identify non-apoptotic low-level caspase-3 as therapeutic target in pemphigus vulgaris.
    Luyet C; Schulze K; Sayar BS; Howald D; Müller EJ; Galichet A
    PLoS One; 2015; 10(3):e0119809. PubMed ID: 25748204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens.
    Chernyavsky AI; Arredondo J; Kitajima Y; Sato-Nagai M; Grando SA
    J Biol Chem; 2007 May; 282(18):13804-12. PubMed ID: 17344213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
    Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
    J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis--possible involvement of the EGF receptor.
    Frusić-Zlotkin M; Raichenberg D; Wang X; David M; Michel B; Milner Y
    Autoimmunity; 2006 Nov; 39(7):563-75. PubMed ID: 17101500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
    Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
    J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgaris.
    Chernyavsky A; Amber KT; Agnoletti AF; Wang C; Grando SA
    J Biol Chem; 2019 Mar; 294(12):4520-4528. PubMed ID: 30692201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface.
    Di Zenzo G; Di Lullo G; Corti D; Calabresi V; Sinistro A; Vanzetta F; Didona B; Cianchini G; Hertl M; Eming R; Amagai M; Ohyama B; Hashimoto T; Sloostra J; Sallusto F; Zambruno G; Lanzavecchia A
    J Clin Invest; 2012 Oct; 122(10):3781-90. PubMed ID: 22996451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3.
    Tsunoda K; Ota T; Aoki M; Yamada T; Nagai T; Nakagawa T; Koyasu S; Nishikawa T; Amagai M
    J Immunol; 2003 Feb; 170(4):2170-8. PubMed ID: 12574390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptides Targeting the Desmoglein 3 Adhesive Interface Prevent Autoantibody-induced Acantholysis in Pemphigus.
    Heupel WM; Müller T; Efthymiadis A; Schmidt E; Drenckhahn D; Waschke J
    J Biol Chem; 2009 Mar; 284(13):8589-95. PubMed ID: 19164289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.
    Femiano F
    Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic human monoclonal antibody against desmoglein 3.
    Yeh SW; Cavacini LA; Bhol KC; Lin MS; Kumar M; Duval M; Posner MR; Ahmed AR
    Clin Immunol; 2006 Jul; 120(1):68-75. PubMed ID: 16635589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation.
    Saito M; Stahley SN; Caughman CY; Mao X; Tucker DK; Payne AS; Amagai M; Kowalczyk AP
    PLoS One; 2012; 7(12):e50696. PubMed ID: 23226536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology.
    Marchenko S; Chernyavsky AI; Arredondo J; Gindi V; Grando SA
    J Biol Chem; 2010 Feb; 285(6):3695-3704. PubMed ID: 20007702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes.
    Cirillo N; Femiano F; Gombos F; Lanza A
    Immunol Lett; 2009 Feb; 122(2):208-13. PubMed ID: 19200441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic pathogenic effects of combined mouse monoclonal anti-desmoglein 3 IgG antibodies on pemphigus vulgaris blister formation.
    Kawasaki H; Tsunoda K; Hata T; Ishii K; Yamada T; Amagai M
    J Invest Dermatol; 2006 Dec; 126(12):2621-30. PubMed ID: 16841036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversial role of antibodies against linear epitopes of desmoglein 3 in pemphigus vulgaris, as revealed by semiquantitative living cell immunofluorescence microscopy and in-cell ELISA.
    Lanza A; Perillo L; Landi C; Femiano F; Gombos F; Cirillo N
    Int J Immunopathol Pharmacol; 2010; 23(4):1047-55. PubMed ID: 21244754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actin reorganization contributes to loss of cell adhesion in pemphigus vulgaris.
    Gliem M; Heupel WM; Spindler V; Harms GS; Waschke J
    Am J Physiol Cell Physiol; 2010 Sep; 299(3):C606-13. PubMed ID: 20554911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis is not required for acantholysis in pemphigus vulgaris.
    Schmidt E; Gutberlet J; Siegmund D; Berg D; Wajant H; Waschke J
    Am J Physiol Cell Physiol; 2009 Jan; 296(1):C162-72. PubMed ID: 18987254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris.
    Shimizu A; Ishiko A; Ota T; Tsunoda K; Koyasu S; Amagai M; Nishikawa T
    Arch Dermatol Res; 2002 Oct; 294(7):318-23. PubMed ID: 12373337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of pemphigus autoimmunoglobulins with epidermal cells: activation of the fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients.
    Frusic-Zlotkin M; Pergamentz R; Michel B; David M; Mimouni D; Brégégère F; Milner Y
    Ann N Y Acad Sci; 2005 Jun; 1050():371-9. PubMed ID: 16014554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.